news paper icon

Analyzed News

Roche's Tecentriq wins speedy U.S. FDA review for small cell lung cancer

Swiss group Roche Holding AG said on Wednesday its Tecentriq immunotherapy mixed with chemotherapy won priority review from the U.S. regulator for treating a type of lung cancer, a potential boost to the drug that has been trailing rivals' revenues. [Source]

Publication Date:


Category: healthNews

Topics: review, cancer, lung, tecentriq, speedy

Source Link:

Related Articles